This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Gc Cell Corporation. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Su Hyun Gwon: Innovator in Chimeric Antigen Receptor Technology
Introduction
Su Hyun Gwon is a notable inventor based in Yongin-si, South Korea. He has made significant contributions to the field of immunotherapy, particularly through his work on chimeric antigen receptors (CARs). His innovative approach aims to enhance the anticancer activity of immune cells, which is crucial in the fight against cancer.
Latest Patents
Su Hyun Gwon holds a patent for a chimeric antigen receptor and natural killer cells expressing the same. This invention provides a chimeric antigen receptor that includes an intracellular signaling domain featuring the whole or a portion of an OX40 ligand (CD252). This advancement is designed to improve the anticancer activity of immune cells, thereby offering promising therapeutic options for cancer treatment.
Career Highlights
Gwon is currently associated with Gc Cell Corporation, where he continues to develop innovative solutions in the field of cancer immunotherapy. His work is characterized by a commitment to enhancing the efficacy of immune responses against tumors.
Collaborations
Some of his notable coworkers include Yu Kyeong Hwang and Sung Yoo Cho, who contribute to the collaborative efforts in advancing research and development in their field.
Conclusion
Su Hyun Gwon's contributions to the development of chimeric antigen receptors represent a significant advancement in cancer treatment. His innovative work continues to inspire progress in immunotherapy and offers hope for improved patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile